| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Martin William Dewhurst is Director at TTRX. Martin William Dewhurst's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $208K at current prices.
Martin William Dewhurst has 2 Form 4 filings on record from January 2026 to June 2026, all as Director at Turn Therapeutics (TTRX), 2026.
The 2 reported transactions were 1 option or other derivative award and 1 stock award.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria